摘要
目的观察小剂量阿替普酶(50mg)溶栓方案对于肺栓塞的疗效。方法回顾性分析2011年12月至2014年12月瑞安市人民医院收治的CTPA确诊肺栓塞患者35例,给予50mg阿替普酶治疗后的临床资料。结果患者治疗后心率、呼吸频率等均有明显的降低,且具有统计学意义(P<0.05)。CTPA显示肺部栓塞24h溶栓有效率为94.29%。结论 50mg阿替普酶溶栓方案治疗肺栓塞有显著疗效。
OBJECTIVE To observe the effect of 50mg Alteplase fibrinolytic scheme for pulmonary embol- ism. METHODS We analyzed 35 patients who were received in The People Hospital of Ruian Municipality from 2011.12 to 2014. 12 and they were randomised to 50mg Ahplase. RESULTS The HR,RR were improved among these patients. CTPA showed that the effective rate of thrombolysis in 24h was 94. 29%. CONCLUSION 50mg A1- teplase fibrinolytic scheme is effective for the treatment of pulmonary embolism.
出处
《海峡药学》
2015年第11期73-75,共3页
Strait Pharmaceutical Journal
关键词
阿替普酶
溶栓方案
肺栓塞
Aheplase
Fibrinolytic scheme
Pulmonary embolism
